GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Manuka Inc (OTCPK:MNKA) » Definitions » Capex-to-Revenue

Manuka (Manuka) Capex-to-Revenue : 0.00 (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Manuka Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Manuka's Capital Expenditure for the three months ended in Sep. 2023 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2023 was $0.18 Mil.

Hence, Manuka's Capex-to-Revenue for the three months ended in Sep. 2023 was 0.00.


Manuka Capex-to-Revenue Historical Data

The historical data trend for Manuka's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Manuka Capex-to-Revenue Chart

Manuka Annual Data
Trend
Capex-to-Revenue

Manuka Quarterly Data
Jun22 Sep22 Jun23 Sep23
Capex-to-Revenue - 0.07 - -

Competitive Comparison of Manuka's Capex-to-Revenue

For the Household & Personal Products subindustry, Manuka's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Manuka's Capex-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Manuka's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Manuka's Capex-to-Revenue falls into.



Manuka Capex-to-Revenue Calculation

Manuka's Capex-to-Revenue for the fiscal year that ended in . 20 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- () /
=N/A

Manuka's Capex-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.176
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Manuka  (OTCPK:MNKA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Manuka Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Manuka's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Manuka (Manuka) Business Description

Traded in Other Exchanges
N/A
Address
3 Eliezer Vardinon Street, Petach Tikva, ISR, 4959507
Manuka Inc is a beauty company that develops and distributes premium-quality skincare products, that are based on M?nuka honey and bee venom. Its skincare products are manufactured in Israel by its vendor, Chic with M?nuka honey ingredients. The company imports Manuka honey from its supplier in New Zealand, Waitemata Honey pursuant to the Supply Agreement. Currently, it operates only in Israel through the online platform. Its website and mobile applications currently offer six cosmetic skincare products: Face Serum with Manuka Honey and Bee Venom; Face Serum with enhanced Vitamin C; Day Cream; Night nourishing Cream; Eye Cream; and Face Cleanser Gel.
Executives
David Dana officer: Chief Financial Officer 3 ELIEZER VARDINON ST., PETACH TIKVA L3 4959507
Shimon Citron director, officer: Chief Executive Officer
Brian M Culley officer: Chief Executive Officer 6725 MESA RIDGE ROAD, SUITE 100, SAN DIEGO CA 92121
Peter N. Payne officer: Chief Executive Officer C/O NEW YORK GLOBAL INNOVATIONS INC., 18 E. 16TH STREET, SUITE 307, NEW YORK NY 10003
Dana Wolf officer: Chief Scientific Officer 18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Tonak Ltd. 10 percent owner 18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Israel Alfassi director 18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Chanan Morris officer: Chief Financial Officer 30 HAKTORET STREET, EFRAT L3 90435
Arias Roberto Alonso Jimenez director C/O NEW YORK GLOBAL INNOVATIONS INC., 18 EAST 16TH ST., SUITE 307, NEW YORK NY 10003
Tomer Assis officer: Chief Financial Officer C/O INKSURE TECHNOLOGIES INC., 18 EAST 16TH ST., SUITE 307, NEW YORK NY 10003
David W Sass director, officer: Secretary 260 MADISON AVE 18TH FLR, NEW YORK NY 10016
David Avner officer: CHIEF FINANCIAL OFFICER 1 HAMADA ST, REHOVOT L3 76703
Jonathan Bettsak director C/O INKSURE LTD 1 HAMADA ST., THE RABIN SCIENCE PARK, REHOVOT L3 76703
Tal Gilat officer: President and CEO C/O INKSURE, 1 HAMADA ST., REHOVOT L3 76703
Alon Raich director C/O ICTS INTERNATIONAL, N.V., BIESBOSCH 225, 1181 JC AMSTELVEEN P7 0000000000

Manuka (Manuka) Headlines

No Headlines